Paige Henley Published on: March 27, 2025 Editor Cybersecurity firm CyberSEK uncovered a massive breach of six million sensitive records from Oracle Cloud, affecting more than 140,000 customers. The breach…
Penka Hristovska Published on: March 27, 2025 Senior Editor Signal is a pretty secure app — apparently, so much so that the Trump administration is discussing looming US military action there.…
Eric Goldstein Published on: March 27, 2025 Chief Editor A recent report from cybersecurity firm Bitdefender reveals that hundreds of “malicious” Android apps, part of a large-scale ad fraud campaign…
More than a million people of nearly all ages lace up their trainers and hit the pavement in a marathon every year. And while running has a suite of health benefits, a long-distance race may not be such good news for the brain in the weeks that follow. Source of Article
New research found that taking a placebo pill, knowing that it contains no active ingredients, reduced the intensity of premenstrual syndrome (PMS) symptoms by a whopping 79%, substantially more than taking the usual side-effect-causing medications. Source of Article
There are probably a million reasons why you don't need a new pair of pants. But there are at least 18 reasons why you want these particular adventure pants from Caligo. Source of Article
While sustainably-grown wood can be an eco-friendly building material, its relatively low tensile strength limits its potential applications. That could soon change, however, thanks to a new self-densifying technique for creating super-strong wood. Source of Article
Tern introduced a compact Bosch-powered cargo bike back in 2017 that could haul gear or kids where its larger models couldn't. The company improved the formula in 2020, and has now pretty much redesigned everything for the third-generation GSD family. Source of Article
Penka Hristovska Updated on: March 25, 2025 Senior Editor Russia is taking a significant step in tightening control over internet access. Last week, the country’s media and telecommunications regulator, Roskomnadzor,…
It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks like we'll have the next generation of these breakthrough weight loss and diabetes medicines on shelves by early next year. Source of Article
Copyright © 2025 Nasni Consultants Ltd. All Rights Reserved